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a  b  s  t  r  a  c  t
We  evaluated  the  effects  of aerobic  exercise  (AE)  on airway  inﬂammation,  exhaled  nitric  oxide  levels
(ENO), airway  remodeling,  and  the  expression  of  Th1,  Th2 and  regulatory  cytokines  in  a  guinea pig  asthma
model.  Animals  were  divided  into  4 groups:  non-trained  and  non-sensitized  (C),  non-sensitized  and  AE
(AE), ovalbumin-sensitized  and  non-trained  (OVA),  and  OVA-sensitized  and  AE  (OVA  + AE). OVA  inhala-




sensitization.  Compared  to  the  other  groups,  the  OVA  +  AE  group  had  a reduced  density  of  eosinophils
and  lymphocytes,  reduced  expression  of  interleukin  (IL)-4  and  IL-13  and  an  increase  in  epithelium  thick-
ness (p <  0.05).  AE  did not  modify  airway  remodeling  or ENO  in  the  sensitized  groups  (p >  0.05).  Neither
OVA  nor  AE  resulted  in  differences  in the expression  of  IL-2,  IFN-,  IL-10  or  IL1-ra.  Our  results  show  that
AE  reduces  the  expression  of Th2  cytokines  and  allergic  airway  inﬂammation  and induces  epithelium
remodeling  in sensitized  guinea  pigs.. Introduction
Asthma is deﬁned as a chronic airway inﬂammatory disease
GINA, 2009) involving eosinophil inﬁltration, an event orches-
rated by Th2 lymphocytes (Holgate, 2008). Classically, the Th2
attern of T-cell activation and inﬂammation involves an aug-
entation in the production of pro-inﬂammatory cytokines such
s interleukin (IL)-4, IL-5 and IL-13 (Feleszko et al., 2006). The
ncreased Th2 proﬁle in asthma is related to the release of dif-
erent pro-inﬂammatory mediators; among them, nitric oxide has
een well studied. Increased levels of ENO, which directly reﬂect
he pulmonary production of NO, have already been demonstrated
n asthmatic patients (Reid et al., 2003) and in animal models of
sthma (Prado et al., 2005, 2006).
Aerobic exercise (AE) has been used as an important compo-
ent of rehabilitation programs for asthmatic patients and results
n reduced dyspnea (Ram et al., 2009), exercise-induced bron-
hospasm and corticosteroid consumption along with improved
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2007; Mendes et al., 2010, 2011). Originally, the beneﬁts of AE
have been attributed to an increase in aerobic exercise capacity that
raises the ventilatory threshold, thereby decreasing minute ventila-
tion during exercise and the perception of breathlessness (Clark and
Cochrane, 1999). However, over the last few years, experimental
models of asthma have demonstrated that AE may  reduce allergic
airway inﬂammation and remodeling (Vieira et al., 2007; Silva et al.,
2010).
Several studies have demonstrated that AE reduces allergic
airway inﬂammation and remodeling and the Th2 response by
decreasing NF-B expression (Pastva et al., 2004; Vieira et al.,
2008, 2011; Silva et al., 2010) and increasing the expression of the
anti-inﬂammatory cytokine IL-10 (Vieira et al., 2007, 2008, 2011;
Silva et al., 2010). However, these studies have two  main criti-
cisms: (i) AE was  initiated at the same time as airway sensitization,
which does not represent what occurs in asthmatic patients and
(ii) mouse models of asthma using ovalbumin usually require peri-
toneal allergen sensitization to develop the Th2 allergic response,
which provokes a systemic immune response with allergic inﬂam-
mation predominantly in the lung vessels and parenchyma rather
© 2012 Elsevier B.V. Open access under the Elsevier OA license.than in the airways, which occurs in the lungs of asthmatic individ-
uals (Wenzel and Holgate, 2006).
Guinea pigs have been used in experimental models to eval-






















































Airway smooth muscle area, airway epithelium thickness and
edema were deﬁned as the number of point hitting, respectively,
in smooth muscle and epithelial cells and peribronchial edema.2 C.R. Olivo et al. / Respiratory Physi
apidly sensitized to aerolized ovalbumin without the need for
ntraperitoneal injections. These results in an airway response
o challenge similar to that of asthmatic phenotypes, including a
obust bronchoconstriction that is lacking in other rodents (Bice
t al., 2000; Wenzel and Holgate, 2006; Zosky and Sly, 2007). In
ddition, the pharmacological responses of guinea pig airways are
ery similar to those of humans in comparison to any other animal
odel (Ressmeyer et al., 2006).
Therefore, the aim of this study was to evaluate the effects
f aerobic exercise on airway inﬂammation and remodeling
n a model of chronic allergic airway inﬂammation in guinea
igs.
. Methods
This study was approved by the review board for human and
nimal studies of the School of Medicine of the University of
ão Paulo (São Paulo, Brazil). All of the animals in the study
eceived human care in compliance with the Guide for the Care
nd Use of Laboratory Animals (NHI publication 85-23, revised
985).
.1. Animals and study design
Thirty male Hartley guinea pigs (250–280 g) were divided into
our groups: Control (non-exercised and non-sensitized; C group;
 = 7); Aerobic Exercise (non-sensitized and aerobically exercised;
E group; n = 7); Ovalbumin (OVA-sensitized and non-exercised;
VA group; n = 8) and OVA + AE (sensitized and aerobically exer-
ised; OVA + AE group; n = 8).
.2. Sensitization protocol
Animals were placed in an acrylic box (30 cm × 15 cm × 20 cm)
oupled to an ultrasonic nebulizer (Soniclear, SP, Brazil) and
eceived seven sessions of OVA inhalation solution diluted in ster-
le saline (NaCl 0.9%). The Control and AE groups (non-sensitized)
eceived the same number of inhalation sessions with sterile
aline. All inhalation sessions lasted 15 min  or until the animal
isplayed respiratory distress (sneezing, coryza, cough or retrac-
ion of the thoracic wall) as previously described. OVA inhalation
as performed for 8 weeks (3×/week) with increasing concentra-
ions (from 1 to 20 mg/ml) to avoid OVA tolerance (Tiberio et al.,
997).
.3. Aerobic exercise training
Animals were initially adapted to the treadmill for 5 days (5 min,
% inclination, 0.3 km/h). Next, a maximal exercise treadmill test
as performed to establish the intensity of AE training (low inten-
ity corresponded to 50% of the maximal speed). The maximal
xercise treadmill test consisted of a 5-min warm-up (8% inclina-
ion, 0.3 km/h) followed by a gradual increase in treadmill speed
0.3 km/h every 3 min). The maximal exercise capacity was consid-
red to be the maximal speed that animals were able to run after
eceiving 10 mechanical stimuli as previously described (Vieira
t al., 2007). The speed of the AE was calculated as the aver-
ge of the maximal speed achieved for each animal group in the
aximal exercise treadmill test. AE was conducted on a treadmill
Imbramed®, RS, Brazil) for 6 weeks, beginning in the 3rd week of
VA inhalation; the sensitized animals continued to receive OVAnhalation during this period. Subsequently, the maximal treadmill
xercise test was repeated to evaluate aerobic performance. The
on-aerobically trained groups (Control and OVA) were not submit-
ed to the AE protocol and were instead adapted to the treadmill for& Neurobiology 182 (2012) 81– 87
3 days per week (8% inclination, 0.3 km/h, 5 min per session) until
the last treadmill exercise test.
2.4. Measurement of exhaled nitric oxide (ENO)
Forty-eight hours after the last session of training and OVA
or saline inhalation, all animals were anesthetized with sodium
thiopental (170 mg/kg, i.p.), tracheostomized, and mechanically
ventilated (60 breaths/min; 6 ml/kg of tidal volume) with a
mechanical ventilator for small animals (Harvard, Rodent Venti-
lator Model 683, MA,  USA) (Prado et al., 2005). Next, a sample of
exhaled air was  collected in a Mylar bag at the expiratory output
valve for 5 min  (Mehta et al., 1998; Ramos et al., 2010). ENO was
measured by chemiluminescences using a rapidly responding ana-
lyzer (NOA 280; Sievers Instruments, CO, USA). The equipment was
calibrated before each measurement with a certiﬁed 47 parts per
billion (ppb) NO source (White Martins, SP, BRA). To avoid environ-
mental contamination, a zero NO ﬁlter (Sievers Instruments) was
attached to the inspiratory input. The results were expressed as
parts of ENO per billion.
2.5. Histological and immunohistochemical analyses
After ENO collection, a 3-cm incision was  made in the abdomen,
and blood from the inferior cava vein was  collected (5 ml).
The animals were then exsanguinated by cutting the abdomi-
nal aorta. A positive end-expiratory pressure of 5 cmH2O with
4% paraformaldehyde was applied through the cannulated tra-
chea; the anterior chest wall was  removed; and the lungs were
removed en bloc and immediately immersed in 4% paraformalde-
hyde for 24 h. Next, sections were processed with parafﬁn
embedding, and 5-m slices were obtained and stained with hema-
toxylin and eosin for routine histological analysis and with Luna
for eosinophil detection. Immunohistochemistry was also per-
formed with anti-IL-4 (1:300), anti-IL-13 (1:150), anti-IL-2 (1:150),
anti-IFN- (1:150), anti-IL-10 (1:50) and anti-IL-1ra (1:120) anti-
bodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA) using the
biotin–streptavidin–peroxidase method (Vieira et al., 2007; Silva
et al., 2010).
The peribronchial density of eosinophils, lymphocytes, and cells
positive for IL-4, IL-13, IFN-, IL-2, IL-10 and IL-1ra was assessed
by conventional morphometry using an ocular microscope with an
integrating eyepiece with 100-point and 50 lines (point-counting
technique) with a known area (10,000 m2) at 1000× magniﬁca-
tion. Counting was performed in ﬁve non-cartilaginous airways per
animal at 1000× magniﬁcation (Vieira et al., 2007). The results are
expressed as cells per square millimeter.
The bronchoconstriction index (BI) was deﬁned as the number
of intercepts between the lines of the grid and the basal mem-
brane divided by the square root of the number of points hitting
the airway lumen (BI = NI/
√
L). NI = the number of intercepts that
cross basal membrane, which is proportional to the perimeter of
the airway; L = number of points hitting the airway lumen, which
is proportional to the intraluminal area. BI was quantiﬁed in ﬁve
non-cartilaginous airways per animal at 400× magniﬁcation (Sakae
et al., 1994).This value was divided by the number of intercepts that cross the
basal membrane, which is proportional to the perimeter of the air-
way (Sakae et al., 1994; Vieira et al., 2007). Measurements were
performed in ﬁve airways per animal at 1000× magniﬁcation.
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Table  1
Exercise performance and immunoglobulin levels in studied groups.
Groups Aerobic Treadmill Test (min) Immunoglobulins (log)
Initial test Final test IgE IgG1
C 18.1 ± 1.3 23.3 ± 1.7 0 0
AE  22.0 ± 2.1 38.5 ± 5.0* 0 0
OVA 14.7 ±  3.4 21.2 ± 3.2 2.9 ± 1.7** 5.7 ± 2.9**
OVA + AE 20.4 ± 2.0 40.5 ± 3.8* 2.7 ± 2.2** 4.8 ± 3.7**
Data are presented as mean ± SD. C = control group; AE = aerobic training group;
OVA = sensitized and non-trained group; OVA + AE = sensitized and trained group.








































Fig. 1. Peribronchial counting of eosinophils (A) and lymphocytes (B). *p < 0.001
when compared with C, AE and OVA + AE and **p < 0.01 when compared with C and** p < 0.001 as compared with other groups.
.6. Passive cutaneous anaphylaxis (PCA) for OVA-speciﬁc IgE
nd IgG1
After blood collection from the cava vein, the samples were
mmediately centrifuged for 15 min  (5 ◦C; 1000 rpm). Serum sam-
les were stored at −70 ◦C until the assay was performed.
A PCA reaction was used to detect and estimate the levels of
naphylactic IgE and IgG1 OVA-speciﬁc antibodies as previously
escribed (Ovary, 1964; Mota and Perini, 1970). Brieﬂy, the back of a
aïve guinea pig was shaved, and 0.1 ml  of different serum dilutions
as injected intradermally. Thirty naïve guinea pigs were used to
valuate the PCA, and the serum from each animal was included in
he study (n = 30). After a long latent period of 48 h for IgE or a short
eriod of 24 h for IgG1, the animals were challenged intravenously
i.v.) with 1 ml  of a 0.5% solution of Evans blue in saline (0.9% NaCl)
ontaining 1 mg  of antigen (ovalbumin). The animals were eutha-
ized 30 min  after injection of the antigen, and the diameters of the
lue spots on the inner surface of the ﬂayed skin were measured.
o detect the IgG1-type antibody, the serum was  heated for 3 h at
6 ◦C to inactivate IgE activity; the heated serum was injected for
CA after a short latency period. The PCA titers were deﬁned as the
ighest dilutions that gave an intradermal allergic reaction larger
han 5 mm in diameter in triplicate tests (Ovary, 1964; Mota and
erini, 1970).
.7. Statistical analysis
One-way analysis of variance (ANOVA) followed by a
tudent–Newman–Keuls post hoc test (parametric data) or ANOVA
n ranks followed by Dunn’s post hoc test (non-parametric data)
ere used to compare the different parameters between groups.
he values were expressed as the mean ± SD for parametric data
nd as the median (variance) for non-parametric data. The level of
igniﬁcance was set at p < 0.05.
. Results
.1. Physical exercise capacity and PCA for OVA-speciﬁc IgE and
gG1
Table 1 shows the maximal exercise capacity obtained in ini-
ial and ﬁnal tests for each group before and after the AE protocol.
nly animals from the trained groups (AE and OVA + AE groups)
xhibited a signiﬁcant increase in exercise capacity when compared
ith the animals in the non-trained groups (C and OVA) (p < 0.001;
able 1). The OVA and OVA + AE groups had increases in the OVA-
peciﬁc IgE and IgG1 titers compared to the non-sensitized groups
p < 0.001; Table 1). However, AE did not have any effect on the
VA-speciﬁc IgE or IgG1 titers (p > 0.05).AE.
3.2. Lung tissue inﬂammation
OVA sensitization increased the density of eosinophil (Fig. 1A)
and lymphocyte (Fig. 1B) migration to the peribronchial com-
partment compared to the non-sensitized groups (C and AE
groups; p < 0.001). Importantly, AE training in the sensitized ani-
mals (OVA + AE group) resulted in a very signiﬁcant decrease
in the density of peribronchial eosinophils and lymphocytes
(p < 0.001).
3.3. Expression of Th2 and Th1 Cytokines
The peribronchial density of cells positive for Th2 cytokines (IL-4
and IL-13) was  increased in the OVA group compared to the non-
sensitized groups (p < 0.05). AE training in the sensitized animals
(OVA + AE group) resulted in a decrease in IL-13 (Fig. 2A) and IL-4
(Fig. 2B) compared to the OVA group. The expression of Th1 (IL-
2 and IFN-) (Fig. 3A and B, respectively) and regulatory cytokines
(IL-10 and IL-1ra) (Fig. 4A and B, respectively) remained unchanged
by either OVA exposure or by exercise training; no differences were
observed between the groups.
3.4. Exhaled nitric oxide (ENO)
Chronic OVA exposure increased the ENO levels compared to
those in the non-sensitized groups (p < 0.05; Fig. 4C). However,
AE did not change the ENO levels in either the sensitized or non-
sensitized group (p > 0.05).









wig. 2. Expression of IL-13 (A) and IL-4 (B) by the inﬂammatory cells. *p < 0.001 when
ompared with C, AE and OVA + AE.
.5. Peribronchial edema, epithelium thickness,
ronchoconstriction index and airway smooth muscle area
The animals exposed to OVA had higher values of peribronchial
dema compared to the saline-exposed animals (p < 0.01). AE train-
ng in the animals exposed to OVA resulted in a reduced edema
ndex at the same level as the non-sensitized groups (C and
E) (Fig. 5A). OVA sensitization also induced an increase in air-
ay epithelium thickness (Fig. 5B), the bronchoconstriction index
Fig. 3. Expression of IL-2 (A) and IFN- (B) by the inﬂammatory cells.& Neurobiology 182 (2012) 81– 87
(Fig. 5C) and the smooth muscle area of the airway (Fig. 5D)
(p < 0.05). AE training did not reduce the OVA-induced increase
in the bronchoconstriction index (Fig. 5B; p > 0.05) or the airway
smooth muscle thickness (Fig. 5D; p > 0.05). Interestingly, AE train-
ing in the sensitized animals (OVA + AE group) induced an increase
in epithelium thickness compared to the values observed in the
OVA group (Fig. 5B).
4. Discussion
In the present study, we  showed that aerobic exercise (AE) train-
ing inhibited OVA-induced eosinophil and lymphocyte inﬁltration
in airway walls as well as the expression of Th2 cytokines (IL-4 and
IL-13) by inﬂammatory cells. In addition, AE reduced the amount of
edema in the peribronchial area in OVA-sensitized animals. In con-
trast, AE in OVA-sensitized animals did not have any effect on the
thickness of airway smooth muscle, the bronchoconstriction index
or on the levels of exhaled nitric oxide (ENO). In addition, neither
OVA sensitization nor AE had any effect on the expression of Th1
cytokines (IL-2 and IFN-).
Many beneﬁts of AE for asthmatics have been described (Neder
et al., 1999; Fanelli et al., 2007; Mendes et al., 2010); however, the
physiopathological basis for such beneﬁts remains poorly under-
stood. Traditionally, the effect of AE on asthmatic patients has
been attributed to a decrease in the ventilatory threshold (Satta,
2000; Ram et al., 2009); however, recent studies in murine mod-
els of asthma have suggested that AE might have a possible
anti-inﬂammatory effect on chronic allergy airway inﬂammation
(Pastva et al., 2004; Vieira et al., 2007, 2011; Silva et al., 2010).
Our group and others have shown some effects of AE on chronic
allergic lung inﬂammation (Pastva et al., 2004; Vieira et al., 2007,
2008, 2011; Silva et al., 2010). However, many criticisms have been
raised concerning the mouse model of asthma involving the use of
ovalbumin. Wenzel and Holgate (2006) suggest that mouse mod-
els of asthma provide insights into immunologic processes but have
shortcomings that continue to limit the understanding and treat-
ment of human asthma. Several reasons are given as limitations: (i)
mouse models of asthma require artiﬁcial intra-peritoneal allergen
sensitization and adjunctive stimulation and provoke a system-
atic rather than a pulmonary allergic sensitization, which can even
extend to include cardiovascular effects (Bice et al., 2000); (ii) the
site of inﬂammation is mainly located in the parenchyma and the
lung vascular vessels instead of the airways as occurs in human
asthma (Wenzel and Holgate, 2006); and (iii) mice have lower levels
of eosinophils in the airways following antigen challenge compared
to guinea pigs and humans with asthma (Korsgren et al., 1997).
Our results showed that sensitized guinea pigs submitted to
AE training had a reduction in eosinophil migration as well as in
the migration of lymphocytes to the airways, which reinforced
previous studies showing that AE reduces eosinophilic inﬂamma-
tion in mouse models of asthma (Pastva et al., 2004; Vieira et al.,
2007). However, the reduction in lymphocyte migration to the
airways following AE was previously unknown and is interesting
because lymphocytes orchestrate eosinophilic migration. To better
understand the effect of AE on reducing eosinophilic migration,
we quantiﬁed the expression of Th2 cytokines. The results show
that AE reversed the OVA-induced expression of IL-4 and IL-13,
suggesting an important effect of AE on the pro-inﬂammatory
cytokines involved in allergic airway inﬂammation. Despite the
fact that AE has been shown to reduce IL-4 expression in mouse
studies (Pastva et al., 2004; Vieira et al., 2007, 2008, 2011), this
is the ﬁrst study in guinea pigs to show that AE can also reduce
the expression of IL-13. IL-13 is an important interleukin in the
pathophysiology of asthma that modulates eosinophilic inﬂam-
mation and mucus hypersecretion (Zhu et al., 1999). In addition, a
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Fig. 4. Expression of IL-10 (A), IL-1ra (B) by the inﬂammatory cells and ENO levels (C). *p < 0.001 when compared with C and AE groups; ppb: parts per billion.
Fig. 5. Edema index (A), airway epithelium thickness (B), bronchoconstriction index (C) and airway smooth muscle area (D). **p < 0.05 when compared with all other groups.
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tudy by Willis-Karp et al. demonstrated that these pro-asthmatic
ffects of IL-13 are independent of IgE production (Wills-Karp
t al., 1998). Interestingly, in our study, AE reduced eosinophilic
nﬂammation but not OVA-induced IgE levels, suggesting that
he anti-inﬂammatory effects of AE in a guinea pig model of
sthma could be modulated by other factors not involving IgE
roduction.
We quantiﬁed these mediators based on our knowledge of
revious ﬁndings showing that AE improves the immunologic
esponse by increasing levels of Th1 cytokines (Ray and Cohn,
000) or the anti-inﬂammatory cytokine IL-10 (Nakagome et al.,
005). However, our results have shown that AE did not modify
he expression of either Th1 cytokines (IL-2 and IFN-) or IL-10.
ltogether, our results may  suggest that AE acts directly on Th2
ytokine expression; however, the precise mechanism for such an
ffect needs to be evaluated in the near future.
Levels of exhaled nitric oxide (ENO) have been considered to
e a marker of airway inﬂammation in asthmatic patients and are
ncreased in asthmatic patients (Prieto et al., 2002). Suman and Beck
2002) suggested that the inhibition of NO synthesis slightly atten-
ates exercise-induced bronchoconstriction. Although we  showed
hat OVA sensitization increased ENO to levels similar to those
bserved in another OVA-induced asthma model in guinea pigs
Prado et al., 2005), this increase was not reduced by AE, which sug-
ests that the effect of AE was not mediated by NO in our guinea
ig model of asthma.
Airway remodeling is an important feature of the asthmatic air-
ay and seems to be a consequence of non-resolved inﬂammation
s well as an imbalance in the healing and repair process (Irvin and
enzel, 1995). Airway remodeling is characterized by epithelium
esquamation, the increased deposition of extra-cellular matrix
roteins on the airway wall and airway smooth muscle hypertro-
hy and hyperplasia (Larché et al., 2003). In our animal model, OVA
xposure induced an increase in airway edema and bronchocon-
triction as well as in the epithelium and smooth muscle. Although
E reduced airway edema, AE had no effect on airway smooth mus-
le or on bronchoconstriction. One limitation of our study is that
e did not evaluate central (cartilaginous) airways that play an
mportant role in the pulmonary mechanical changes secondary to
ntigen challenge in asthmatic patients and murine animal model
f asthma. It is possible that the absence of reduction on airway
mooth muscle and bronchoconstriction induced by exercise train-
ng may  be due the fact that we have evaluated only peripheral and
ot central airways. In contrast, aerobic training induced a thicken-
ng of the airway epithelium. The effect on the airway epithelium
bserved in our study was previously reported by Chimenti et al.
2007), who demonstrated that aerobic training increases apopto-
is and the proliferation rate of the airway epithelium independent
f any previous inﬂammation.
Our results have also shown that AE did not reduce OVA-induced
irway remodeling in our guinea pig model of asthma, contrary
o other mouse studies from our group and others demonstrating
he beneﬁcial effects of AE on airway remodeling (Pastva et al.,
004; Vieira et al., 2007; Silva et al., 2010). It has been shown
hat the airway smooth muscle of guinea pigs most resembles that
f humans because the airway smooth muscle has the following
eatures: (i) it has similar mechanisms of contractile and relaxant
gonists with similar potency and efﬁcacy (Persson et al., 1997;
ack et al., 1984); (ii) it initiates reﬂex bronchospasm (Canning,
006); and (iii) it is promptly sensitized to aerolized inhaled anti-
en and involves dramatic eosinophil and lymphocyte migration. In
ontrast to results from our own and other groups obtained using
ouse models of asthma (Pastva et al., 2004; Vieira et al., 2007,
011; Silva et al., 2010), our results may  suggest that AE did not
everse OVA-induced airway remodeling. However, the discrepan-
ies between the effects of AE in these animal models of asthma& Neurobiology 182 (2012) 81– 87
highlight the urgent need for human studies that investigate the
effects of AE on airway remodeling in asthmatic individuals.
In conclusion, our study suggests that aerobic exercise decreases
chronic allergic airway inﬂammation in guinea pigs by decreasing
eosinophil and lymphocyte inﬁltration as well as the expression of
Th2 cytokines but fails to reduce airway remodeling in this speciﬁc
animal model of asthma.
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